Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (251-260 of 625) with videos related to

Pageof 63
Sort By:
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthropathies. Part I: current evidence of efficacyCarlo Palazzi, Salvatore D'Angelo, Fabrizio Cantini, et al.
Journal of Clinical Medicine|June 24, 2022
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR StudySalvatore D'Angelo, Carlo Salvarani, Francesca Marando, et al.
The American Journal of Surgical Pathology|September 13, 2014
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlationsAlberto Cavazza, Francesco Muratore, Luigi Boiardi, et al.
Respirology Case Reports|May 25, 2023
One-year clinical experience on the use of Nintedanib in systemic sclerosisLuca Magnani, Amelia Spinella, Sofia Testoni, et al.
Clinical and Experimental Rheumatology|January 9, 2026
Potential clinical utility of quantitative 18F-FDG PET/CT parameters in evaluating vascular inflammation in giant cell arteritisCaterina Ricordi, Rexhep Durmo, Paolo Giorgi Rossi, et al.
Immunobiology|April 3, 2024
Comparable cytokine release ex-vivo by whole blood from COVID-19 patients with and without non-invasive ventilationMartina Bonacini, Ilaria Ferrigno, Alessandro Rossi, et al.
The Journal of Rheumatology|June 3, 2016
Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective StudyEnnio Lubrano, Fabio Massimo Perrotta, Maria Manara, et al.
The Journal of Rheumatology|October 7, 2003
Vascular endothelial growth factor gene polymorphisms in giant cell arteritisLuigi Boiardi, Bruno Casali, Davide Nicoli, et al.
The Journal of Rheumatology. Supplement|July 4, 2012
Adalimumab in psoriatic arthritisCarlo Salvarani, Nicolò Pipitone, Mariagrazia Catanoso, et al.
Rheumatology (Oxford, England)|May 14, 2025
Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failureAlessandro Tomelleri, Milena Bond, Chiara Marvisi, et al.
Pageof 63

Showing results (251-260 of 625) with videos related to

Sort By:
Pageof 63
Clinical and Experimental Rheumatology|November 2, 2011
Etanercept in spondyloarthropathies. Part I: current evidence of efficacyCarlo Palazzi, Salvatore D'Angelo, Fabrizio Cantini, et al.
Journal of Clinical Medicine|June 24, 2022
Residual Disease in Patients with Axial Spondyloarthritis: A Post-Hoc Analysis of the QUASAR StudySalvatore D'Angelo, Carlo Salvarani, Francesca Marando, et al.
The American Journal of Surgical Pathology|September 13, 2014
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlationsAlberto Cavazza, Francesco Muratore, Luigi Boiardi, et al.
Respirology Case Reports|May 25, 2023
One-year clinical experience on the use of Nintedanib in systemic sclerosisLuca Magnani, Amelia Spinella, Sofia Testoni, et al.
Clinical and Experimental Rheumatology|January 9, 2026
Potential clinical utility of quantitative 18F-FDG PET/CT parameters in evaluating vascular inflammation in giant cell arteritisCaterina Ricordi, Rexhep Durmo, Paolo Giorgi Rossi, et al.
Immunobiology|April 3, 2024
Comparable cytokine release ex-vivo by whole blood from COVID-19 patients with and without non-invasive ventilationMartina Bonacini, Ilaria Ferrigno, Alessandro Rossi, et al.
The Journal of Rheumatology|June 3, 2016
Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective StudyEnnio Lubrano, Fabio Massimo Perrotta, Maria Manara, et al.
The Journal of Rheumatology|October 7, 2003
Vascular endothelial growth factor gene polymorphisms in giant cell arteritisLuigi Boiardi, Bruno Casali, Davide Nicoli, et al.
The Journal of Rheumatology. Supplement|July 4, 2012
Adalimumab in psoriatic arthritisCarlo Salvarani, Nicolò Pipitone, Mariagrazia Catanoso, et al.
Rheumatology (Oxford, England)|May 14, 2025
Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failureAlessandro Tomelleri, Milena Bond, Chiara Marvisi, et al.
Pageof 63